← Lobby register
Disclosed budget
€50,000 — €99,999
Meetings 12mo
2
Policy files
0
Accredited passes
0
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 02 Jun 2025 | Florika Fink-Hooijer Director-General | Supply chain vulnerabilities | — |
| 02 Jun 2025 | Florika Fink-Hooijer Director-General | Supply chain vulnerabilities | SRC |
| 16 Jun 2023 | Karolina Herbout-Borczak Cabinet member | visit to the Medichem manufacturing site | — |
| 16 Jun 2023 | Karolina Herbout-Borczak Cabinet member | visit to the Medichem manufacturing site | SRC |
Mission & Goals
MEDICHEM IS AN INDEPENDENT, VERTICALLY INTEGRATED COMPANY SPECIALIZED IN THE DEVELOPMENT AND PRODUCTION OF ACTIVE PHARMACEUTICAL INGREDIENTS AND FINISHED DOSAGE FORMS FOR THE GLOBAL GENERICS INDUSTRY.
EU Legislative Interests
CRITICAL MEDICINES ALLIANCE PHARMACEUTICAL LEGISLATION SUSTAINABILITY LEGISLATION INTELLECTUAL PROPERTY LEGISLATION MEDICINES AND FINE CHEMICALS BIOTECH ACT INDUSTRIAL ACCELERATOR ACT
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
MEDICINES FOR EUROPE EUROPEAN FINE CHEMICALS GROUP (SECTOR GROUP WITHIN CEFIC)